In addition, the risk of developing ischemic heart disease (IHD) generally is associated with relatively low blood levels of Flt3 ligand, whereas, for patients suffering from abdominal obesity (AO), the relative risk of early ischemic heart disease (IHD) is linked to low levels of IL-4 [60]. Here, FLT3LG is linked to Abdominal obesity.